Search Results

Research Study Search Results

1. Neuroscience

   1. Brain Tumor

      1. The Ivy Glioblastoma Atlas Project: A Multi-site Initiative to Create a Web-based Resource for Glioblastoma Research. Greg Foltz, MD
      2. Phase 1 Study of the Metabolism and Distribution of a Subpharmacologic Dose of Lightly-labeled 14CTemozolomide in Newly Diagnosed Glioblastoma Patients Greg Foltz, MD
      3. A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM John Henson, MD
      4. A Phase II Clinical Trial Evaluating DCVax®-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme Greg Foltz, MD

   2. Brain Tumor /Neuroendocrine

      1. Efficacy and safety of pasireotide LAR in patients with rare tumors of neuroendocrine origin William H. Ludlam, MD

   3. Brain Tumor /Neurosurgery

      1. The Comprehensive Neuro-Oncology Data Repository (CONDR): Prospective Collection of Clinical Tissue and Imaging Data for the Study of Patients with Brain Tumors. Sarah C. Jost, MD

   4. Craniotomy /Interventional

      1. Intravenous acetaminophen for craniotomy patients Arthur M. Lam, M.D.

   5. Epilepsy

      1. Tissue Procurement and Repository for Future Neuroscience Studies Ryder Gwinn, MD
      2. Responsive Neurostimulator (RNS) System - Long-term Treatment Clinic Investigation Ryder Gwinn, MD
      3. A combined FMRI and electrophysiological study of human sensory perception Jehuda P Sepkuty, MD

   6. Epilepsy /Genetic

      1. Protocol For Research of Genetic Epilepsy Marcio Sotero de Menezes, MD

   7. Multiple Sclerosis

      1. XenoPort Arbaclofen Study Angeli Mayadev, MD
      2. Temporal gene expression and microRNA profiling in the blood of patients with demyelinating disease treated with steroids. James Bowen, MD
      3. Pain Research in Multiple Sclerosis (PRIME) Angeli Mayadev, MD
      4. JCV Antibody Program in patients with Relapsing MS and who are Receiving or Considering Treatment with Tysabri Lily Jung, MD
      5. Fingolimod (FTY720) Lily Jung, MD
      6. Double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of teriflunomide versus placebo in patients with a first clinical episode suggestive of multiple sclerosis Pavle Repovic, MD, PhD
      7. Double-blind placebo-controlled parallel-group study to evaluate the safety and efficacy of two doses of oral Dalfampridine extended release tablets (5 mg and 10 mg twice daily) in patients with Multiple Sclerosis Angeli Mayadev, MD
      8. Diogenix - MS Specificity James Bowen, MD
      9. CLINICAL CROSS RELAXATION IMAGING AT 3 TESLA MAGNET FIELD STRENGTH METHODOLOGY DEVELOPMENT AND APPLICATION TO MULTIPLE SCLEROSIS Lily Jung Henson, MD
      10. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With Secondary Progressive Multiple Sclerosis Pavle Repovic, MD, PhD
      11. A multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients with Relapsing Multiple Sclerosis. Lily Jung, MD
      12. 109MS301 - A Randomized, Multi-center, Double-blind, Placebo-controlled, Dose-comparison Study to Determine the Efficacy and Safety of BG00012 in Subjects with Relapsing-Remitting Multiple Sclerosis (RRMS) Lily Jung, MD
      13. 101MS402 TYGRIS - Tysabri Global Observational Program in Safety Lily Jung, MD

   8. Neuro-Ophthalmology

      1. Pfizer NAION Eugene May, MD
      2. NORDIC IIHTT Steven Hamilton, MD

   9. Neuro-Otology

      1. Electric-Acoustic System (EAS) Douglas D Backous, MD

   10. Pituitary

       1. VRS317 William H. Ludlam, MD
       2. Pasireotide/SOM230C (Acromegaly) William Ludlam, MD
       3. Cushing's LAR. CSOM230G2304 William H. Ludlam, MD
       4. CSOM230B (Cushing's) William Ludlam, MD

   11. Pituitary Tumor /Acromegaly

       1. Assess safety and efficacy of double-blind pasireotide LAR 40 mg and pasireotide LAR 60 mg versus openlabel octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly William H. Ludlam, MD

   12. Psychiatry

       1. A clinical evaluation for the management of patients with major depressive disorder, single or recurrent episode, with deep brain stimulation Ken Melman, MD

   13. Spine

       1. The EMPOWER study: Eon Mini™ Study - Product Options for Wellness, Effectiveness, and Relief; A Multi-Centered Evaluation of Patients with Chronic Pain of the Trunk and/or Limbs using Paddle Lead(s). Ryder Gwinn, MD
       2. Prospective Randomized Investigation of Radiofrequency Targeted Vertebral Augmentation (The PRIORi-T Trial) Glen David, MD
       3. 'Evidence' study-Spinal Cord Stimulation with Precision SCS System versus Reoperation Ryder Gwinn, MD

   14. Stroke

       1. Ultrasound and Systemic Tissue Plasminogen Activator for Emergent Revascularization in Acute Ischemic Stroke William Likosky, MD
       2. Carotid Occlusion Surgical Study (COSS) David W. Newell, MD
       3. A RANDOMIZED DOUBLE-BLIND PARALLEL-GROUP PLACEBO-CONTROLLED PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DESMOTEPLASE IN PATIENTS WITH ACUTE ISCHEMIC STROKE-"DIAS-4" William Likosky, MD